National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

This is a funding opportunity from the National Cancer Institute for investigator-initiated early phase clinical trials focused on cancer treatment and diagnosis. It requires an R01 clinical trial application and falls under CFDA numbers 93.393, 93.399, 93.394, and 93.395.